Allosteric inhibition of endogenous HIV-1 reverse transcription by TIBO derivatives

Zeger Debyser; Anne‐Mieke Vandamme; Rudi Pauwels; Jan Desmyter; De Clercq Erik

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1991

New antiviral target on HIV-1 reverse transcriptase revealed by TIBO derivatives

Zeger Debyser, Rudi Pauwels, K Andries, Jan Desmyter, Michael J. Kukla, Paj Janssen, De Clercq Erik

Article1990

HIV-1 specific inhibition of reverse transcriptase by TIBO-derivatives: a new mechanism of antiviral action discovered by drug screening

Rudi Pauwels, K Andries, Zeger Debyser, Jan Desmyter, De Clercq Erik, Paj Janssen

Article1991

Allosteric properties of heterodimeric HIV-1 reverse transcriptase

Zeger Debyser, Rudi Pauwels, K Andries, Jan Desmyter, Yves Engelborghs, Paj Janssen, De Clercq Erik

Article1992

Kinetics of Inhibition of Endogenous Human Immunodeficiency Virus Type 1 Reverse Transcription by 2',3'-Dideoxynucleoside 5'-

Zeger DebyserS, Anne‐Mieke Vandamme, Rudi Pauwels, Masanori BabaO, Jan Desmyter, De Clercq Erik

Article1990

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

Rudi Pauwels, Koen Andries, Jan Desmyter, Dominique Schols, Michael J. Kukla, Henry J. Breslin, Alfons Raeymaeckers, Jozef Van Gelder, Robert Woestenborghs, J. Heykants, K H Schellekens, M. Janssen, De Clercq Erik, Paul A. J. Janssen